{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T11:08:46Z","timestamp":1779361726137,"version":"3.51.4"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Erythropoietin (EPO) is classically viewed as a kidney-derived hormone essential for erythropoiesis, yet accumulating evidence places it at the center of complex interactions between the kidney and the immune system. The kidney is both a frequent target of immune-mediated injury and an organ with distinctive tolerogenic properties, capable in experimental models of inducing acceptance of otherwise rejection-prone allografts. Herein, we review experimental and clinical data showing that EPO, through its homodimeric EPO receptor (EPOR) or heterodimer EPOR\/CD131 receptors, shapes both adaptive and innate immunity in ways that are directly relevant to tolerance and rejection. EPO selectively restrains effector T cells while preserving and expanding regulatory T cells through a macrophage-mediated production of active transforming growth factor \u03b2. EPO inhibits T\n                      <jats:sub>H<\/jats:sub>\n                      17 differentiation and skews the T follicular helper\/T follicular regulatory (T\n                      <jats:sub>FH<\/jats:sub>\n                      \/T\n                      <jats:sub>FR<\/jats:sub>\n                      ) balance toward regulation, resulting in reduced germinal center B-cell activity and diminished allo- and autoantibody production. In macrophages, EPO signaling limits proinflammatory cytokine production, promotes an M2-like phenotype, enhances clearance of apoptotic cells, and counteracts trained immunity programs that otherwise accelerate allograft rejection. Studies in posttransplant erythrocytosis and lupus models support a nonredundant role for endogenous EPO as a physiological mechanism of peripheral immune tolerance. Similarly, the activation of the EPO\u2013EPOR axis in tumor-associated macrophages drives immune suppression and resistance to immune checkpoint inhibitors. Integrating these insights, we propose that EPO functions as a key rheostat of renal and systemic immunity, and discuss how harnessing this pathway may offer novel strategies to promote transplant tolerance while minimizing oncologic risk.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/tp.0000000000005683","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T21:00:09Z","timestamp":1773176409000},"page":"e1200-e1208","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The Kidney\u2013immune Axis: How Erythropoietin Regulates Tolerance and Rejection"],"prefix":"10.1097","volume":"110","author":[{"given":"Chiara","family":"Cantarelli","sequence":"first","affiliation":[{"name":"Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum\u2013University of Bologna, Bologna, Italy."},{"name":"Nephrology, Dialysis and Kidney Transplant Unit, IRCCS Azienda Ospedaliero, University of Bologna, Bologna, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Bin","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum\u2013University of Bologna, Bologna, Italy."},{"name":"Nephrology, Dialysis and Kidney Transplant Unit, IRCCS Azienda Ospedaliero, University of Bologna, Bologna, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Angeletti","sequence":"additional","affiliation":[{"name":"Nephrology, Dialysis, and Transplantation, IRCCS Istituto Giannina Gaslini, Genoa, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaquin","family":"Manrique","sequence":"additional","affiliation":[{"name":"Nephrology Service, Hospital Universitario de Navarra. Navarra Medical Research Institute (IdiSNA), Pamplona, Spain."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Cravedi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"key":"R1-20260521","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1146\/annurev-immunol-090122-045843","article-title":"Immunology of kidney disease.","volume":"42","author":"Foresto-Neto","year":"2024","journal-title":"Annu Rev Immunol"},{"key":"R2-20260521","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/MOT.0000000000000594","article-title":"Why some organ allografts are tolerated better than others: new insights for an old question.","volume":"24","author":"Hull","year":"2019","journal-title":"Curr Opin Organ Transplant"},{"key":"R3-20260521","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1182\/blood.V82.5.1507.1507","article-title":"Erythropoietin structure-function relationships: high degree of sequence homology among mammals.","volume":"82","author":"Wen","year":"1993","journal-title":"Blood"},{"key":"R4-20260521","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0092-8674(95)90234-1","article-title":"Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor.","volume":"83","author":"Wu","year":"1995","journal-title":"Cell"},{"key":"R5-20260521","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1111\/ajt.15369","article-title":"Erythropoietin, a multifaceted protein with innate and adaptive immune modulatory activity.","volume":"19","author":"Cantarelli","year":"2019","journal-title":"Am J Transplant"},{"key":"R6-20260521","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1182\/blood.V94.6.1864","article-title":"Regulation of the erythropoietin gene.","volume":"94","author":"Ebert","year":"1999","journal-title":"Blood"},{"key":"R7-20260521","doi-asserted-by":"crossref","first-page":"10925","DOI":"10.1073\/pnas.0805594105","article-title":"Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin.","volume":"105","author":"Brines","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R8-20260521","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/sj.ki.5001546","article-title":"Discovering erythropoietin\u2019s extra-hematopoietic functions: biology and clinical promise.","volume":"70","author":"Brines","year":"2006","journal-title":"Kidney Int"},{"key":"R9-20260521","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.jacc.2005.01.043","article-title":"High serum erythropoietin level is associated with smaller infarct size in patients with acute myocardial infarction who undergo successful primary percutaneous coronary intervention.","volume":"45","author":"Namiuchi","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R10-20260521","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.carrev.2015.01.008","article-title":"Administration of erythropoietin in patients with myocardial infarction: does it make sense? An updated and comprehensive meta-analysis and systematic review.","volume":"16","author":"Ali-Hassan-Sayegh","year":"2015","journal-title":"Cardiovasc Revasc Med"},{"key":"R11-20260521","doi-asserted-by":"crossref","first-page":"743926","DOI":"10.3389\/fphar.2022.743926","article-title":"The effect of erythropoietin and its derivatives on ischemic stroke therapy: a comprehensive review.","volume":"13","author":"Ma","year":"2022","journal-title":"Front Pharmacol"},{"key":"R12-20260521","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.pediatrneurol.2014.06.008","article-title":"Erythropoietin: emerging role of erythropoietin in neonatal neuroprotection.","volume":"51","author":"Rangarajan","year":"2014","journal-title":"Pediatr Neurol"},{"key":"R13-20260521","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1907423","article-title":"A randomized trial of erythropoietin for neuroprotection in preterm Infants.","volume":"382","author":"Juul","year":"2020","journal-title":"N Engl J Med"},{"key":"R14-20260521","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1056\/NEJMoa2119660","article-title":"Trial of erythropoietin for hypoxic-ischemic encephalopathy in newborns.","volume":"387","author":"Wu","year":"2022","journal-title":"N Engl J Med"},{"key":"R15-20260521","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41413-021-00157-x","article-title":"Epo\/EpoR signaling in osteoprogenitor cells is essential for bone homeostasis and Epo-induced bone loss.","volume":"9","author":"Rauner","year":"2021","journal-title":"Bone Res"},{"key":"R16-20260521","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/jbmr.3900","article-title":"High plasma erythropoietin predicts incident fractures in elderly men with normal renal function: The MrOS Sweden Cohort.","volume":"35","author":"Kristjansdottir","year":"2020","journal-title":"J Bone Miner Res"},{"key":"R17-20260521","doi-asserted-by":"crossref","first-page":"386","DOI":"10.5812\/traumamon.7099","article-title":"Local erythropoietin injection in tibiofibular fracture healing.","volume":"17","author":"Bakhshi","year":"2013","journal-title":"Trauma Mon"},{"key":"R18-20260521","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/ncomms1526","article-title":"Disrupted erythropoietin signalling promotes obesity and alters hypothalamus proopiomelanocortin production.","volume":"2","author":"Teng","year":"2011","journal-title":"Nat Commun"},{"key":"R19-20260521","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1182\/blood-2002-01-0124","article-title":"Erythroid-specific expression of the erythropoietin receptor rescued its null mutant mice from lethality.","volume":"100","author":"Suzuki","year":"2002","journal-title":"Blood"},{"key":"R20-20260521","doi-asserted-by":"crossref","first-page":"8114","DOI":"10.1038\/s41467-024-52352-z","article-title":"Erythropoietin regulates energy metabolism through EPO-EpoR-RUNX1 axis.","volume":"15","author":"Yin","year":"2024","journal-title":"Nat Commun"},{"key":"R21-20260521","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41392-020-00232-5","article-title":"Carbamylated erythropoietin regulates immune responses and promotes long-term kidney allograft survival through activation of PI3K\/AKT signaling.","volume":"5","author":"Na","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"R22-20260521","doi-asserted-by":"crossref","first-page":"e1993","DOI":"10.1038\/cddis.2015.338","article-title":"A novel cyclic helix B peptide inhibits dendritic cell maturation during amelioration of acute kidney graft rejection through Jak-2\/STAT3\/SOCS1.","volume":"6","author":"Yang","year":"2015","journal-title":"Cell Death Dis"},{"key":"R23-20260521","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.transproceed.2018.03.015","article-title":"EPO derivative ARA290 attenuates early renal allograft injury in rats by targeting NF-kappaB pathway.","volume":"50","author":"Yan","year":"2018","journal-title":"Transplant Proc"},{"key":"R24-20260521","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/TP.0000000000001026","article-title":"A nonhematopoietic erythropoietin analogue, ARA 290, inhibits macrophage activation and prevents damage to transplanted islets.","volume":"100","author":"Watanabe","year":"2016","journal-title":"Transplantation"},{"key":"R25-20260521","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1681\/ASN.2013090945","article-title":"Immunosuppressive effects of erythropoietin on human alloreactive T cells.","volume":"25","author":"Cravedi","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"R26-20260521","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1681\/ASN.2016101100","article-title":"Erythropoietin receptor-mediated molecular crosstalk promotes T cell immunoregulation and transplant survival.","volume":"28","author":"Purroy","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"R27-20260521","doi-asserted-by":"crossref","first-page":"e127428","DOI":"10.1172\/jci.insight.127428","article-title":"Erythropoietin inhibits SGK1-dependent TH17 induction and TH17-dependent kidney disease.","volume":"5","author":"Donadei","year":"2019","journal-title":"JCI Insight"},{"key":"R28-20260521","doi-asserted-by":"crossref","first-page":"15845","DOI":"10.3389\/ti.2025.15845","article-title":"Increased Treg in Kidney Transplant Recipients With Erythrocytosis.","volume":"38","author":"Bigatti","year":"2025","journal-title":"Transpl Int"},{"key":"R29-20260521","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1097\/00029330-200809020-00005","article-title":"Involvement of CD4+CD25+ regulatory T cells in the pathogenesis of polycythaemia vera.","volume":"121","author":"Zhao","year":"2008","journal-title":"Chin Med J (Engl)"},{"key":"R30-20260521","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.coi.2021.11.004","article-title":"T follicular helper cells and their impact on humoral responses during pathogen and vaccine challenge.","volume":"74","author":"Juno","year":"2022","journal-title":"Curr Opin Immunol"},{"key":"R31-20260521","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/MOT.0000000000001018","article-title":"Role of T follicular helper and T follicular regulatory cells in antibody-mediated rejection: new therapeutic targets?","volume":"27","author":"Zhang","year":"2022","journal-title":"Curr Opin Organ Transplant"},{"key":"R32-20260521","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1681\/ASN.2021010098","article-title":"Erythropoietin reduces auto- and alloantibodies by inhibiting T follicular helper cell differentiation.","volume":"32","author":"Guglielmo","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"R33-20260521","doi-asserted-by":"crossref","first-page":"1195662","DOI":"10.3389\/fimmu.2023.1195662","article-title":"Endogenous erythropoietin has immunoregulatory functions that limit the expression of autoimmune kidney disease in mice.","volume":"14","author":"Bin","year":"2023","journal-title":"Front Immunol"},{"key":"R34-20260521","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41419-020-2276-8","article-title":"Erythropoietin and its derivatives: from tissue protection to immune regulation.","volume":"11","author":"Peng","year":"2020","journal-title":"Cell Death Dis"},{"key":"R35-20260521","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.immuni.2011.01.002","article-title":"Erythropoietin contrastingly affects bacterial infection and experimental colitis by inhibiting nuclear factor-kappaB-inducible immune pathways.","volume":"34","author":"Nairz","year":"2011","journal-title":"Immunity"},{"key":"R36-20260521","doi-asserted-by":"crossref","first-page":"12177","DOI":"10.1038\/ncomms12177","article-title":"Phagocyte respiratory burst activates macrophage erythropoietin signalling to promote acute inflammation resolution.","volume":"7","author":"Luo","year":"2016","journal-title":"Nat Commun"},{"key":"R37-20260521","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.immuni.2016.01.002","article-title":"Erythropoeitin signaling in macrophages promotes dying cell clearance and immune tolerance.","volume":"44","author":"Luo","year":"2016","journal-title":"Immunity"},{"key":"R38-20260521","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ajt.2025.10.013","article-title":"Erythropoietin prolongs graft survival in mice by counteracting trained immunity.","volume":"26","author":"Bin","year":"2026","journal-title":"Am J Transplant"},{"key":"R39-20260521","doi-asserted-by":"crossref","first-page":"e158856","DOI":"10.1172\/jci.insight.158856","article-title":"Linking erythropoietin to Treg-dependent allograft survival through myeloid cells.","volume":"7","author":"Horwitz","year":"2022","journal-title":"JCI Insight"},{"key":"R40-20260521","doi-asserted-by":"crossref","first-page":"682749","DOI":"10.3389\/fimmu.2021.682749","article-title":"Cyclic helix B peptide prolongs skin allograft survival via inhibition of B cell immune responses in a murine model.","volume":"12","author":"Zheng","year":"2021","journal-title":"Front Immunol"},{"key":"R41-20260521","doi-asserted-by":"crossref","first-page":"e1924","DOI":"10.1371\/journal.pone.0001924","article-title":"a potent inducer of peripheral immuno\/inflammatory modulation in autoimmune EAE.","volume":"3","author":"Yuan","year":"2008","journal-title":"PLoS One"},{"key":"R42-20260521","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.brainres.2004.11.036","article-title":"Erythropoietin treatment improves neurological functional recovery in EAE mice.","volume":"1034","author":"Zhang","year":"2005","journal-title":"Brain Res"},{"key":"R43-20260521","doi-asserted-by":"crossref","first-page":"639370","DOI":"10.3389\/fimmu.2021.639370","article-title":"Erythropoietin in lupus: unanticipated immune modulating effects of a kidney hormone.","volume":"12","author":"Eswarappa","year":"2021","journal-title":"Front Immunol"},{"key":"R44-20260521","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1111\/jcmm.13608","article-title":"Non-erythropoietic erythropoietin-derived peptide protects mice from systemic lupus erythematosus.","volume":"22","author":"Huang","year":"2018","journal-title":"J Cell Mol Med"},{"key":"R45-20260521","doi-asserted-by":"crossref","first-page":"102629","DOI":"10.1016\/j.jaut.2021.102629","article-title":"Erythropoietin administration expands regulatory T cells in patients with autoimmune hepatitis.","volume":"119","author":"McEachern","year":"2021","journal-title":"J Autoimmun"},{"key":"R46-20260521","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000318897","article-title":"Twist and shout: one decade of meta-analyses of erythropoiesis-stimulating agents in cancer patients.","volume":"125","author":"Bohlius","year":"2011","journal-title":"Acta Haematol"},{"key":"R47-20260521","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijc.11178","article-title":"Mammary tumor latency is increased in mice lacking the inducible nitric oxide synthase.","volume":"106","author":"Ellies","year":"2003","journal-title":"Int J Cancer"},{"key":"R48-20260521","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cellimm.2016.05.004","article-title":"Erythropoietin increases macrophage-mediated T cell suppression.","volume":"306-307","author":"Wood","year":"2016","journal-title":"Cell Immunol"},{"key":"R49-20260521","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/s41586-025-09824-z","article-title":"Erythropoietin receptor on cDC1s dictates immune tolerance.","volume":"650","author":"Zhang","year":"2025","journal-title":"Nature"},{"key":"R50-20260521","doi-asserted-by":"crossref","first-page":"eadr3026","DOI":"10.1126\/science.adr3026","article-title":"Tumor-derived erythropoietin acts as an immunosuppressive switch in cancer immunity.","volume":"388","author":"Chiu","year":"2025","journal-title":"Science"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005683","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T11:00:29Z","timestamp":1779361229000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000005683","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"value":"0041-1337","type":"print"},{"value":"1534-6080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]}}}